New research reveals a severe wildfire risk facing American landmarks. Over half of historic sites...
Dexcom joins the FDA’s digital health pilot program to accelerate innovative medical technologies with real-world...
Menin inhibitors offer new hope for AML treatment by targeting molecular drivers in 40% of...